Switch to:

Anacor Pharmaceuticals Inc (ANAC) Ownership Data

Short Interest History (%)

This is the historical short interest of Anacor Pharmaceuticals Inc, as measured by the Short Percentage Of Float.

Date Short Interest
June 15, 201616.96
May 31, 201614.59
May 13, 201621.49
April 29, 201617.43
April 15, 201617.77
March 31, 201613.95
March 15, 201613.53
February 29, 201612.43
February 12, 201611.44
January 29, 201610.87
January 15, 201610.82
December 31, 20158.84
December 15, 20158.25
November 30, 20158.16
November 13, 20158.07
October 30, 20158.61
October 15, 20158.91
September 30, 20158.34
September 15, 20159.41
August 31, 20159.24
August 14, 20159.31
July 31, 20159.44
July 15, 20159.88
June 30, 201510.39
June 15, 201510.37
May 29, 20159.62
May 15, 201510.06
April 30, 20159.9
April 15, 201512.12
March 31, 201513.92
March 13, 201519.33
February 27, 201519.24
February 13, 201518.92
January 30, 201518.88
January 15, 201518.55
December 31, 201418.5
December 15, 201419.27
November 28, 201420.11
November 14, 201419.83
October 31, 201420.21
October 15, 201420
September 30, 201419.56
September 15, 201418.5
August 29, 201419.42
August 15, 201420.56
July 31, 201420.33
July 15, 201416.04
June 30, 201411.81
June 13, 201411.15
May 30, 201411.07
May 15, 201410.41
April 30, 20149.7
April 15, 20146.76
March 31, 20146.35
March 14, 20145.88
February 28, 20146.61
February 14, 201417.84
January 31, 201419.1
January 15, 201420.12
December 31, 201319.93
December 13, 201317.61
November 29, 201316.22
November 15, 201314.68
October 31, 201313.87
October 15, 201314.36
September 30, 201313.9
September 13, 201314.41
August 30, 201315.65
August 15, 201317.01
July 31, 201316.16
July 15, 201317.29
June 28, 201315.03
June 14, 201313.64
May 31, 201313.06
May 15, 201312.3
April 30, 201314.14
April 15, 201312.85
March 28, 201310.79
March 15, 20134.21
February 28, 20133.57
February 15, 20133.21
January 31, 201310.11
January 15, 20137.94
December 31, 20129.84
December 14, 20128.6
November 30, 20124.72
November 15, 20123.49
October 31, 20123.01
October 15, 20123.46
September 28, 20122.93
September 14, 20123.34
August 31, 20123.55
August 15, 20123.74
July 31, 20123.71
July 13, 20123.75
June 29, 20123.86
June 15, 20123.08
May 31, 20123.14
May 15, 20122.93
April 30, 20122.93
April 13, 20122.67
March 30, 20122.43
March 15, 20122.59
February 29, 20122.33
February 15, 20122.26
January 31, 20125.84
January 13, 20124.37
December 30, 20113.58
December 15, 20113.59
November 30, 20113.98
November 15, 20114.21
October 31, 20114.39
October 14, 20114.71
September 30, 20114.79
September 15, 20114.63
August 31, 20114.21
August 15, 20113.82
July 29, 20113.77
July 15, 20114.04
June 30, 20114.78
June 15, 20114.1
May 31, 20113.82
May 13, 20113.65
April 29, 20113.37
April 15, 20113.2
March 31, 20113.38
March 15, 20113.27
February 28, 20113.03
February 15, 20112.91
January 31, 20113.1
January 14, 20113.64
December 31, 20104.52
December 15, 20100.99
November 30, 20100.03

Institutional Ownership History (%)

This the Institutional Ownership History of Anacor Pharmaceuticals IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
December 31, 201593.08
September 30, 201599.42
June 30, 201590.59
March 31, 201589.17
December 31, 201493.23
September 30, 201496.82
June 30, 201482.86
March 31, 201491.78
December 31, 201377.63
September 30, 201373.83
June 30, 201373.5
March 31, 201395.25
December 31, 201273.52
September 30, 201276.7
June 30, 201268.79
March 31, 201290.81
December 31, 201156.9
September 30, 201157.99
June 30, 201158.19
March 31, 201160.62
December 31, 201086.76

Insider ownership (%)

This is the historical insider ownership of Anacor Pharmaceuticals Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership
May 31, 20162.19
April 30, 20162.2
March 31, 20162.28
February 29, 20162.32
January 31, 20162.34
December 31, 20152.28
November 30, 20152.33
October 31, 20152.17
September 30, 20152.17
August 31, 20152.17
July 31, 20152.17
June 30, 20152.17
May 31, 20152.16
April 30, 20152.19
March 31, 20152.32
February 28, 20152.44
January 31, 20152.46
December 31, 20141.62
November 30, 20142.59
October 31, 20142.64
September 30, 20142.65
August 31, 20142.65
July 31, 20142.66
June 30, 20142.66
May 31, 20142.66
March 31, 20143.82
February 28, 20142.33
January 31, 20142.56
December 31, 20132.47
November 30, 20132.71
October 31, 20131.78
September 30, 20131.78
August 31, 20131.5
July 31, 20131.49
June 30, 20131.49
May 31, 20131.7
April 30, 20131.7
March 31, 20131.67
January 31, 20131.67
November 30, 20121.67
October 31, 20121.61
September 30, 20121.62
August 31, 20121.63
July 31, 20121.62
June 30, 20121.63
May 31, 20121.64
April 30, 20121.62
March 31, 20121.63
February 29, 20121.61
January 31, 20121.6
December 31, 20111.55
November 30, 20111.61
October 31, 20111.63
September 30, 20111.64
August 31, 20111.65
July 31, 20111.68
June 30, 20111.69
May 31, 20111.71
April 30, 20111.27
March 31, 20111.27
February 28, 20111.34
January 31, 20111.34
December 31, 20101.34
November 30, 20101.34

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Mr. David P. PerryN/A361,3060.8%2014-03-04
Mr. Paul L. BernsPresident and CEO230,3110.51%2016-03-22
Mr. Geoffrey M. ParkerN/A94,8400.21%2015-03-23
Vincent IppolitoEVP & Chief Commercial Officer67,9850.15%2016-03-02
Paul H. KlingensteinN/A58,0010.13%2010-11-30
Dr. Lee T. Zane, M.D.,M.A.S.SVP and Chief Medical Officer44,0440.1%2016-02-03
Dr. Anders D. Hove,M.D.Director33,886less than 0.1%2016-05-16
Ryan T. SullivanEVP and General Counsel30,132less than 0.1%2016-04-29
Sanjay ChandaN/A29,087less than 0.1%2015-03-04
Mr. Graeme BellExecutive VP and CFO11,006less than 0.1%2016-02-03

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value($1000)
Fidelity Management and Research Company   Premium Plus6,727,5212016-03-3115.000.05359,586
Baker Bros Advisors LP   Premium Plus5,122,3752016-03-3111.422.89273,791
Vanguard Group Inc   Premium Plus2,889,5462016-03-316.440.01154,447
Venrock Associates2,737,4832015-04-076.30N/A158,363
Fidelity® Select Biotechnology Portfolio2,603,5222016-04-305.801.58163,345
Palo Alto Investors, LLC   Premium Plus2,219,0422016-03-314.959.21118,608
BlackRock Fund Advisors   Premium Plus1,783,9352016-03-313.980.0295,351
Wellington Management Company LLP   Premium Plus1,771,0582016-03-313.950.0294,662
Franklin Advisers Inc   Premium Plus1,327,4652016-03-312.960.0670,954
State Street Corp   Premium Plus1,315,8922016-03-312.930.0170,334

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK